Follow Slashdot stories on Twitter

 



Forgot your password?
typodupeerror

Slashdot videos: Now with more Slashdot!

  • View

  • Discuss

  • Share

We've improved Slashdot's video section; now you can view our video interviews, product close-ups and site visits with all the usual Slashdot options to comment, share, etc. No more walled garden! It's a work in progress -- we hope you'll check it out (Learn more about the recent updates).

×
Patents

+ - Patents On Genes: Round Two->

Submitted by dstates
dstates (629350) writes "An industry has grown up around patents guaranteeing exclusive access to testing of mutations in specific genes, but recently the Supreme Court rejected a biotechnology patent saying laws of nature cannot be patented, and threw the issue of patents on genes back to the lower courts. The Court of Appeals is now preparing to hear arguments on whether genes can be patented. The results will have major implications. On the one hand, restricting access to whole regions of the human genome will stifle scientific progress. On the other, companies like Myriad Genetics and Optimal Medicine use the patents to protect years of work invested in research, but this also means preventing other companies from offering diagnostics based on competing faster and lower cost technologies to analyze mutations in these genes."
Link to Original Source
This discussion was created for logged-in users only, but now has been archived. No new comments can be posted.

Patents On Genes: Round Two

Comments Filter:

"Kill the Wabbit, Kill the Wabbit, Kill the Wabbit!" -- Looney Tunes, "What's Opera Doc?" (1957, Chuck Jones)

Working...